Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2022
https://www.valueinhealthjournal.com/article/S1098-3015(17)32356-2/fulltext
Title :
Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32356-2&doi=10.1016/j.jval.2017.08.2022
First page :
A736
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1844